| Product Code: ETC314816 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ghana Beta-lactam And Beta-lactamase Inhibitors Market Overview |
3.1 Ghana Country Macro Economic Indicators |
3.2 Ghana Beta-lactam And Beta-lactamase Inhibitors Market Revenues & Volume, 2021 & 2031F |
3.3 Ghana Beta-lactam And Beta-lactamase Inhibitors Market - Industry Life Cycle |
3.4 Ghana Beta-lactam And Beta-lactamase Inhibitors Market - Porter's Five Forces |
3.5 Ghana Beta-lactam And Beta-lactamase Inhibitors Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Ghana Beta-lactam And Beta-lactamase Inhibitors Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.7 Ghana Beta-lactam And Beta-lactamase Inhibitors Market Revenues & Volume Share, By Route Of Administration, 2021 & 2031F |
4 Ghana Beta-lactam And Beta-lactamase Inhibitors Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of bacterial infections in Ghana |
4.2.2 Growing awareness about the importance of antibiotics |
4.2.3 Rise in healthcare expenditure and infrastructure development |
4.3 Market Restraints |
4.3.1 Lack of access to healthcare facilities in rural areas |
4.3.2 High cost of beta-lactam and beta-lactamase inhibitors |
4.3.3 Increasing incidence of antibiotic resistance |
5 Ghana Beta-lactam And Beta-lactamase Inhibitors Market Trends |
6 Ghana Beta-lactam And Beta-lactamase Inhibitors Market, By Types |
6.1 Ghana Beta-lactam And Beta-lactamase Inhibitors Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Ghana Beta-lactam And Beta-lactamase Inhibitors Market Revenues & Volume, By Drug Class, 2021 - 2031F |
6.1.3 Ghana Beta-lactam And Beta-lactamase Inhibitors Market Revenues & Volume, By Penicillin, 2021 - 2031F |
6.1.4 Ghana Beta-lactam And Beta-lactamase Inhibitors Market Revenues & Volume, By Cephalosporin, 2021 - 2031F |
6.1.5 Ghana Beta-lactam And Beta-lactamase Inhibitors Market Revenues & Volume, By Carbapenem, 2021 - 2031F |
6.1.6 Ghana Beta-lactam And Beta-lactamase Inhibitors Market Revenues & Volume, By Monobactam, 2021 - 2031F |
6.1.7 Ghana Beta-lactam And Beta-lactamase Inhibitors Market Revenues & Volume, By Combination, 2021 - 2031F |
6.2 Ghana Beta-lactam And Beta-lactamase Inhibitors Market, By Disease |
6.2.1 Overview and Analysis |
6.2.2 Ghana Beta-lactam And Beta-lactamase Inhibitors Market Revenues & Volume, By Urinary Tract Infection (excluding cUTI), 2021 - 2031F |
6.2.3 Ghana Beta-lactam And Beta-lactamase Inhibitors Market Revenues & Volume, By Respiratory Infection, 2021 - 2031F |
6.2.4 Ghana Beta-lactam And Beta-lactamase Inhibitors Market Revenues & Volume, By Skin Infection, 2021 - 2031F |
6.2.5 Ghana Beta-lactam And Beta-lactamase Inhibitors Market Revenues & Volume, By Complicated Urinary Tract Infection (cUTI), 2021 - 2031F |
6.2.6 Ghana Beta-lactam And Beta-lactamase Inhibitors Market Revenues & Volume, By Complicated Intra-Abdominal Infections (cIAI), 2021 - 2031F |
6.2.7 Ghana Beta-lactam And Beta-lactamase Inhibitors Market Revenues & Volume, By Nosocomial Pneumonia, 2021 - 2031F |
6.2.8 Ghana Beta-lactam And Beta-lactamase Inhibitors Market Revenues & Volume, By Other Diseases, 2021 - 2031F |
6.2.9 Ghana Beta-lactam And Beta-lactamase Inhibitors Market Revenues & Volume, By Other Diseases, 2021 - 2031F |
6.3 Ghana Beta-lactam And Beta-lactamase Inhibitors Market, By Route Of Administration |
6.3.1 Overview and Analysis |
6.3.2 Ghana Beta-lactam And Beta-lactamase Inhibitors Market Revenues & Volume, By Oral, 2021 - 2031F |
6.3.3 Ghana Beta-lactam And Beta-lactamase Inhibitors Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.3.4 Ghana Beta-lactam And Beta-lactamase Inhibitors Market Revenues & Volume, By Others, 2021 - 2031F |
7 Ghana Beta-lactam And Beta-lactamase Inhibitors Market Import-Export Trade Statistics |
7.1 Ghana Beta-lactam And Beta-lactamase Inhibitors Market Export to Major Countries |
7.2 Ghana Beta-lactam And Beta-lactamase Inhibitors Market Imports from Major Countries |
8 Ghana Beta-lactam And Beta-lactamase Inhibitors Market Key Performance Indicators |
8.1 Number of antibiotic prescriptions filled |
8.2 Percentage of antibiotic-resistant bacterial strains |
8.3 Investment in research and development of new antibiotics |
8.4 Number of healthcare facilities offering beta-lactam and beta-lactamase inhibitors |
8.5 Government initiatives to combat antibiotic resistance |
9 Ghana Beta-lactam And Beta-lactamase Inhibitors Market - Opportunity Assessment |
9.1 Ghana Beta-lactam And Beta-lactamase Inhibitors Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Ghana Beta-lactam And Beta-lactamase Inhibitors Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.3 Ghana Beta-lactam And Beta-lactamase Inhibitors Market Opportunity Assessment, By Route Of Administration, 2021 & 2031F |
10 Ghana Beta-lactam And Beta-lactamase Inhibitors Market - Competitive Landscape |
10.1 Ghana Beta-lactam And Beta-lactamase Inhibitors Market Revenue Share, By Companies, 2024 |
10.2 Ghana Beta-lactam And Beta-lactamase Inhibitors Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here